Frat Autism

FRAT®, a diagnostic blood test, measures the presence of autoantibodies that interact (either block or bind) with the activity of the Folate Receptor A (FRA). FRA is responsible for the transport of folate (vitamin B9) into certain tissues, most notably the brain, placenta and ovary. These autoantibodies were detected in numerous individuals with disorders such as Cerebral Folate Deficiency, Autism Spectrum Disorders, sub-fertility in women, and pregnant women carrying fetuses with neural tube defects (NTD). FRAT® measures these autoantibodies, which is an indication that folate may need to be delivered in different ways to enter the brain. This early detection of folate receptor autoantibodies can lead to early intervention and improved prognosis.